Absorption |
Blood-Brain Barrier | BBB+ | 0.8745 |
Human Intestinal Absorption | HIA+ | 0.9909 |
Caco-2 Permeability | Caco2+ | 0.6021 |
P-glycoprotein Substrate | Non-substrate | 0.7865 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9752 |
Non-inhibitor | 0.9394 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9191 |
Distribution |
Subcellular localization | Lysosome | 0.7422 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8092 |
CYP450 2D6 Substrate | Non-substrate | 0.8744 |
CYP450 3A4 Substrate | Non-substrate | 0.8239 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7846 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8731 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9529 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9263 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8397 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9204 |
Non-inhibitor | 0.9427 |
AMES Toxicity | Non AMES toxic | 0.8990 |
Carcinogens | Carcinogens | 0.7166 |
Fish Toxicity | Low FHMT | 0.7858 |
Tetrahymena Pyriformis Toxicity | Low TPT | 1.0000 |
Honey Bee Toxicity | High HBT | 0.6590 |
Biodegradation | Ready biodegradable | 0.9335 |
Acute Oral Toxicity | III | 0.6409 |
Carcinogenicity (Three-class) | Non-required | 0.6425 |